(Q80940181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Survival in patients with brain metastases from breast cancer: the importance of HER-2 status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

April F Eichler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Irene Kuter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Paula Ryan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Lidia Schapira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Jerry Younger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

John W Henson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

2359-2367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis.

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Breast cancer with synchronous metastases: trends in survival during a 14-year period

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Is breast cancer survival improving?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Survival after brain metastases from breast cancer in the trastuzumab era.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Brain metastases in breast cancer; natural history, prognostic factors and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

The natural history of breast cancer patients with brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Characteristics of patients with short and long survivals after detection of intracranial metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Brain metastases in breast cancer: prognostic factors and management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Mechanism of action of anti-HER2 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Surgical treatment of multiple brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Surgical treatment of 70 patients with brain metastases from breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Distribution of brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Diodrast studies of the vertebral and cranial venous systems to show their probable role in cerebral metastases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23468

7 January 2021

Identifiers

DOI

10.1002/CNCR.23468

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18361426%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference